Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05415020 · ClinicalTrials.gov registry record · NA
Determining the Utility of a Behavioral Intervention in Chronic Migraine
A NA study of Migraine and Headache, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT05415020: Recruiting NA study of Migraine and Headache, sponsored by Mayo Clinic.
NCT05415020 is a NA study of Migraine and Headache that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 60 participants, below the 358-participant average among 102 other Migraine trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05415020, a NA study of Migraine and Headache, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
This proposal will involve a pilot study to evaluate the feasibility, acceptability, and outcomes of a lifestyle behavior protocol in managing chronic migraine. Additionally, the proposal will investigate biomolecules that are uniquely involved in chronic migraine patients who respond to the protocol. Successful completion of this proposal will inform the design of a future full-scale behavioral clinical trial to control chronic migraine.
Primary Outcome
Recruitment rate (Feasibility Outcome)
Conditions Studied
Interventions
- BEHAVIORAL Lifestyle Behavior Protocol
- BEHAVIORAL Sham Behavior Protocol
Study Locations (1)
Arizona
- Mayo Clinic - Phoenix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2022-06-29 |
| Est. Completion | 2026-08-14 |
| Phase | NA |
What NCT05415020 shows while recruiting
NCT05415020 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 358-participant average among 102 other Migraine trials with a reported enrollment target (83% lower).
The record links to 6 conditions, with Migraine appearing as the primary indexed condition, and to 2 interventions - of which Lifestyle Behavior Protocol is the first listed.
NCT05415020 reports a single indexed study location in Arizona.
Frequently Asked Questions
What is clinical trial NCT05415020 about?
NCT05415020 is a clinical study titled "Determining the Utility of a Behavioral Intervention in Chronic Migraine". This proposal will involve a pilot study to evaluate the feasibility, acceptability, and outcomes of a lifestyle behavior protocol in managing chronic migraine. Additionally, the proposal will investigate biomolecules that are uniquely involved in chronic migraine patients who respond to the protoco...
What is the current status of trial NCT05415020?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2022-06-29. Estimated completion is 2026-08-14.
What conditions does trial NCT05415020 study?
This clinical trial studies the following conditions: Migraine, Headache, Migraine Disorders, Chronic Migraine, Lifestyle Factors.
What interventions are being tested in trial NCT05415020?
The interventions under investigation include: Lifestyle Behavior Protocol (BEHAVIORAL), Sham Behavior Protocol (BEHAVIORAL).
Who is sponsoring clinical trial NCT05415020?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05415020 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Migraine
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05415020's enrollment target sits among peer trials
60 74th of 102 higher than 25 of 102 other Migraine trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Migraine trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
MMA Embolization for Refractory Chronic Migraine
RECRUITING · NA
-
Stimulation of External Carotid Artery Circulation
RECRUITING · NA
-
Responding With Evidence and Access for Childhood Headaches
RECRUITING · NA
-
Cocoa Extract for Migraine Trial
RECRUITING · NA
-
Migraine in Adolescents
RECRUITING · NA
-
Mind Body Balance for Pediatric Migraine
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI